Medicinal cannabis tea contains variable doses of cannabinoids and no terpenes

Author:

Sønderskov Marie Bach12ORCID,Hasselstrøm Jørgen Bo3,Bahij Rime4,Andersen Charlotte Uggerhøj123ORCID

Affiliation:

1. Department of Clinical Pharmacology Aarhus University Hospital Aarhus N Denmark

2. Department of Biomedicine Aarhus University Aarhus C Denmark

3. Department of Forensic Medicine Aarhus University Aarhus N Denmark

4. Department of Green Technology University of Southern Denmark Odense M Denmark

Abstract

AbstractTea is a recommended way of administration of prescribed cannabis plant products in Denmark. We aimed to investigate the cannabinoid and terpene doses contained in different teas. We analysed tetrahydrocannabinol (THC), tetrahydrocannabinolic acid (THCA), cannabidiol (CBD), cannabidiolic acid (CBDA), and terpene concentrations in three repeated preparations of each type of tea, and in plant material.In standard tea, concentrations of THC were [median (min‐max)] 9.5 (2.3–15), 19 (13–34), and 36 (26–57) μg/mL for products with a labelled content of 6.3%, 14%, and 22% total THC (THC + THCA), respectively. The CBD concentration in tea from a product labelled with 8% total CBD (CBD + CBDA) was 7.5 (1.9–10) μg/mL. Based on this, the recommended starting amount of 0.2 L of the different teas would contain between 0.46 and 11.3 mg THC, and 0.38 to 2.0 mg CBD. Adding creamer before, but not after boiling, increased the THC and CBD concentration 2.3–4.4 and 2.1‐fold, respectively. Terpenes were detected in plant material, but not in tea.The study elucidates THC and CBD doses in different teas, which may assist the clinician's choice of cannabis product. Moreover, it underscores the need for caution as administration as tea can result in exposure to different doses, even when the same cannabis product is used.

Funder

Aarhus Universitet

Publisher

Wiley

Reference38 articles.

1. The Pharmacological History of Cannabis

2. European Monitoring Centre for Drugs and Drug Addiction.European Drug Report 2023: Trends and Developments. Accessed 25 March 2024.https://www.emcdda.europa.eu/publications/european-drug-report/2023_en

3. United Nations Office on Drugs and Crime.World Drug Report 2023. Accessed 25 March 2024.https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2023.html

4. Danish Health Authority.Udbredelse af illegale stoffer i befolkningen og blandt de unge. Narkotikasituationen i Danmark 2024. Delrapport 1. Accessed 25 March 2024.https://sst.dk/da/fagperson/forebyggelse-og-tvaergaaende-indsatser/stoffer/overvaagning-af-narkotikasituationen

5. Ministry of the Interior and Health.Lov om forsøgsordning med medicinsk cannabis. LOV nr 1668 af 26/12/2017. 13.05.2021 Accessed 25 March 2024.https://www.retsinformation.dk/eli/lta/2017/1668

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3